Aims and Scope

Aims and Scope


Nucleic acids received a major boost through the ‘proof of concept’ delivered by the tremendously successful COVID-19 mRNA vaccines. As a result, investment has flooded in, driving new applications and opportunities seemingly on a daily basis. However, this remains a nascent field, which lacks a dedicated provider of both high-level analysis and in-depth technical data. 


Nucleic Acid Insights is specifically designed to address this knowledge gap for all stakeholders who are either active in or just entering the space today. Nucleic Acid Insights provides both the deep technical/scientific know-how and strategic ‘big picture’ insight required to successfully navigate this rapidly evolving space – a unique online resource keeping the nucleic acids field up to date with all the latest news, trends, issues, and breakthroughs.


Nucleic Acid Insights covers all the major RNA and DNA technologies and modalities, including but not limited to:

  • Messenger RNA (mRNA)
  • Plasmid DNA
  • Antisense oligonucleotides (ASO)
  • Phosphorodiamidate morpholino oligonucleotides (PMO) 
  • RNA interference (RNAi), including small interfering RNA (siRNA)
  • Aptamers
  • Micro RNA (miRNA)
  • Guide RNA (gRNA)


These and other nucleic acid modalities and associated delivery technologies will be explored in a wide range of applications spanning the life sciences field, including therapeutic drugs, prophylactic vaccines, raw and starting materials for biomanufacturing, research tools, and diagnostics.


Nucleic Acid Insights - your one-stop-shop for comprehensive coverage of process and analytical development, supply chain, preclinical and clinical R&D, regulation, business/finance, and commercial/market access.